检索结果 - Cyrus V. Hedvat

Refine Results
  1. 1
    Late relapse in primary central nervous system lymphoma: clonal persistence

    Late relapse in primary central nervous system lymphoma: clonal persistence 由 Lakshmi Nayak, Cyrus V. Hedvat, Marc K. Rosenblum, Lauren E. Abrey, Lisa M. DeAngelis

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines

    Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines 由 BR Avalos, JC Gasson, Cyrus V. Hedvat, SG Quan, GC Baldwin, RH Weisbart, RE Williams, DW Golde, JF DiPersio

    出版 1990
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma

    KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma 由 Kyuichi Kadota, Camelia S. Sima, Maria E. Arcila, Cyrus V. Hedvat, Mark G. Kris, David R. Jones, Prasad S. Adusumilli, William D. Travis

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma

    Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma 由 Rony Schaffel, Cyrus V. Hedvat, Julie Teruya‐Feldstein, Daniel O. Persky, Jocelyn Maragulia, Dengna Lin, C. Portlock, Craig H. Moskowitz, Andrew D. Zelenetz

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The ETS Protein MEF Plays a Critical Role in Perforin Gene Expression and the Development of Natural Killer and NK-T Cells

    The ETS Protein MEF Plays a Critical Role in Perforin Gene Expression and the Development of Natural Killer and NK-T Cells 由 H. Daniel Lacorazza, Yasushi Miyazaki, Antonio Di Cristofano, A DeBlasio, Cyrus V. Hedvat, Jin Zhang, Carlos Cordón-Cardo, Shifeng Mao, Pier Paolo Pandolfi, Stephen D. Nimer

    出版 2002
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    PIK3CA Mutation Associates with Improved Outcome in Breast Cancer

    PIK3CA Mutation Associates with Improved Outcome in Breast Cancer 由 Kevin Kalinsky, Lindsay M. Jacks, Adriana Heguy, Sujata Patil, Marija Drobnjak, Umesh Bhanot, Cyrus V. Hedvat, Tiffany A. Traina, David B. Solit, William L. Gerald, Mary Ellen Moynahan

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

    Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias 由 Omar Abdel‐Wahab, Taghi Manshouri, Jay Patel, Kelly L. Harris, JinJuan Yao, Cyrus V. Hedvat, Adriana Heguy, Carlos Bueso-Ramos, Hagop M. Kantarjian, Ross L. Levine, Srđan Verstovšek

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases

    Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases 由 Steven C. Katz, Zubin M. Bamboat, Ajay V. Maker, Jinru Shia, Venu G. Pillarisetty, Adam C. Yopp, Cyrus V. Hedvat, Mithat Gönen, William R. Jarnagin, Yuman Fong, Michael I. D’Angelica, Ronald P. DeMatteo

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome

    Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome 由 Su-Jiang Zhang, Raajit K. Rampal, Taghi Manshouri, Jay Patel, Nana Yaa Mensah, Andrew Kayserian, Todd Hricik, Adriana Heguy, Cyrus V. Hedvat, Mithat Gönen, Hagop M. Kantarjian, Ross L. Levine, Omar Abdel‐Wahab, Srđan Verstovšek

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    PHF6 mutations in adult acute myeloid leukemia

    PHF6 mutations in adult acute myeloid leukemia 由 Pieter Van Vlierberghe, Jay Patel, Omar Abdel‐Wahab, Camille Lobry, Cyrus V. Hedvat, Milagros Balbı́n, Carlos Nicolás, Ángel Ramírez Páyer, Hugo F. Fernández, Martin S. Tallman, Elisabeth Paietta, Ari Melnick, Peter Vandenberghe, Frank Speleman, Iannis Aifantis, Jan Cools, Ross L. Levine, Adolfo A. Ferrando

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans

    HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans 由 Sachie Marubayashi, Priya Koppikar, Tony Taldone, Omar Abdel‐Wahab, Nathan West, Neha Bhagwat, Eloisi Caldas-Lopes, Kenneth N. Ross, Mithat Gönen, Alex Gozman, James H. Ahn, Anna Rodina, Ouathek Ouerfelli, Guangbin Yang, Cyrus V. Hedvat, James E. Bradner, Gabriela Chiosis, Ross L. Levine

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis

    Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis 由 Priya Koppikar, Omar Abdel‐Wahab, Cyrus V. Hedvat, Sachie Marubayashi, Jay Patel, Aviva Goel, Nicole Kucine, Jeffrey R. Gardner, Andrew P. Combs, Kris Vaddi, Patrick J. Haley, Timothy C. Burn, Mark Rupar, Jacqueline Bromberg, Mark Heaney, Elisa de Stanchina, Jordan S. Fridman, Ross L. Levine

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

    The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate 由 Patrick S. Ward, Jay Patel, David R. Wise, Omar Abdel‐Wahab, Bryson D. Bennett, Hilary A. Coller, Justin R. Cross, Valeria R. Fantin, Cyrus V. Hedvat, Alexander E. Perl, Joshua D. Rabinowitz, Martin Carroll, Shinsan M. Su, Kim A. Sharp, Ross L. Levine, Craig B. Thompson

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Akt Phosphorylates the Transcriptional Repressor Bmi1 to Block Its Effects on the Tumor-Suppressing <i>Ink4a-Arf</i> Locus

    Akt Phosphorylates the Transcriptional Repressor Bmi1 to Block Its Effects on the Tumor-Suppressing <i>Ink4a-Arf</i> Locus 由 Yan Liu, Fan Liu, Hao Yu, Xinyang Zhao, Goro Sashida, A DeBlasio, Michael W. Harr, Qing‐Bai She, Zhenbang Chen, Hui‐Kuan Lin, Silvana Di Giandomenico, Shannon Elf, Youyang Yang, Yasuhiko Miyata, Gang Huang, Sílvia Menéndez, Ingo K. Mellinghoff, Neal Rosen, Pier Paolo Pandolfi, Cyrus V. Hedvat, Stephen D. Nimer

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

    Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation 由 Ekaterina Doubrovina, Banu Oflaz-Sozmen, Susan E. Prockop, Nancy A. Kernan, Steven B. Abramson, Julie Teruya‐Feldstein, Cyrus V. Hedvat, Joanne F. Chou, Glenn Heller, Juliet N. Barker, Farid Boulad, Hugo Castro‐Malaspina, Diane George, Ann A. Jakubowski, Guenther Koehne, Esperanza B. Papadopoulos, Andromachi Scaradavou, Trudy N. Small, Ramzi Khalaf, James W. Young, Richard J. O’Reilly

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

    Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies 由 Omar Abdel‐Wahab, Ann Mullally, Cyrus V. Hedvat, Guillermo Garcia‐Manero, Jay Patel, Martha Wadleigh, Sébastien Malinge, JinJuan Yao, Outi Kilpivaara, Rukhmi Bhat, Kety Huberman, Sabrena Thomas, Igor Dolgalev, Adriana Heguy, Elisabeth Paietta, Michelle M. Le Beau, Miloslav Beran, Martin S. Tallman, Benjamin L. Ebert, Hagop M. Kantarjian, Richard M. Stone, D. Gary Gilliland, John D. Crispino, Ross L. Levine

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

    CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia 由 Renier J. Brentjens, Marco L. Davila, Isabelle Rivière, Jae H. Park, Xiuyan Wang, Lindsay G. Cowell, Shirley Bartido, Jolanta Stefanski, Clare Taylor, Malgorzata Olszewska, Oriana Bórquez-Ojeda, Jinrong Qu, Teresa Wasielewska, Qing He, Yvette Bernal, Ivelise Rijo, Cyrus V. Hedvat, Rachel Kobos, Kevin J. Curran, Peter G. Steinherz, Joseph G. Jurcic, Todd Rosenblat, P. Maslak, Mark G. Frattini, Michel Sadelain

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

    The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation 由 Janis M. Taube, Güray Aktürk, Michael Angelo, Elizabeth L. Engle, Sacha Gnjatic, Shirley Greenbaum, Noah F. Greenwald, Cyrus V. Hedvat, Travis J. Hollmann, Jonathan Juco, Edwin R. Parra, Marlon C. Rebelatto, David L. Rimm, Jaime Rodriguez‐Canales, Kurt A. Schalper, Edward C. Stack, Cláudia S. Ferreira, Konstanty Korski, Ana Lako, Scott J. Rodig, Emanuel Schenck, Keith E. Steele, Michael Surace, Michael T. Tetzlaff, Katharina von Loga, Ignacio I. Wistuba, Carlo Bifulco

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

    Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma 由 Richard D. Carvajal, Jeffrey A. Sosman, J. Fernando Quevedo, Mohammed Milhem, Anthony M. Joshua, Ragini R. Kudchadkar, Gerald P. Linette, Thomas F. Gajewski, Jose Lutzky, David H. Lawson, Christopher D. Lao, Patrick J. Flynn, Mark R. Albertini, Takami Sato, Karl D. Lewis, Austin Doyle, Kristin Kathleen Ancell, Katherine S. Panageas, Mark J. Bluth, Cyrus V. Hedvat, Joseph P. Erinjeri, Grazia Ambrosini, Brian P. Marr, David H. Abramson, Mark A. Dickson, Jedd D. Wolchok, Paul B. Chapman, Gary K. Schwartz

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing

    Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing 由 Janis M. Taube, Joel Sunshine, Michael Angelo, Güray Aktürk, Margaret Eminizer, Elizabeth L. Engle, Cláudia S. Ferreira, Sacha Gnjatic, Benjamin Green, Shirley Greenbaum, Noah F. Greenwald, Cyrus V. Hedvat, Travis J. Hollmann, Daniel Jiménez‐Sánchez, Konstanty Korski, Ana Lako, Edwin R. Parra, Marlon C. Rebelatto, David L. Rimm, Scott J. Rodig, Jaime Rodriguez‐Canales, Jeffrey S Roskes, Kurt A. Schalper, Emanuel Schenck, Keith E. Steele, Michael Surace, Alexander S. Szalay, Michael T. Tetzlaff, Ignacio I. Wistuba, Jennifer H. Yearley, Carlo Bifulco

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: